These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 17162625)

  • 41. The problem of delusional ugliness: is it really body dysmorphic disorder?
    Fontenelle LF; Mendlowicz MV; Kalaf J; Versiani M
    World J Biol Psychiatry; 2006; 7(2):110-5. PubMed ID: 16684683
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clomipramine vs desipramine crossover trial in body dysmorphic disorder: selective efficacy of a serotonin reuptake inhibitor in imagined ugliness.
    Hollander E; Allen A; Kwon J; Aronowitz B; Schmeidler J; Wong C; Simeon D
    Arch Gen Psychiatry; 1999 Nov; 56(11):1033-9. PubMed ID: 10565503
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Level of insight and clinical features of obsessive-compulsive disorder with and without body dysmorphic disorder.
    Nakata AC; Diniz JB; Torres AR; de Mathis MA; Fossaluza V; Bragancas CA; Ferrão Y; Miguel EC
    CNS Spectr; 2007 Apr; 12(4):295-303. PubMed ID: 17426667
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hypochondriasis and its relationship to obsessive-compulsive disorder.
    Fallon BA; Qureshi AI; Laje G; Klein B
    Psychiatr Clin North Am; 2000 Sep; 23(3):605-16. PubMed ID: 10986730
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The brown longitudinal obsessive compulsive study: treatments received and patient impressions of improvement.
    Mancebo MC; Eisen JL; Pinto A; Greenberg BD; Dyck IR; Rasmussen SA
    J Clin Psychiatry; 2006 Nov; 67(11):1713-20. PubMed ID: 17196050
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Psychopathologic aspects of body dysmorphic disorder: a literature review.
    Pavan C; Simonato P; Marini M; Mazzoleni F; Pavan L; Vindigni V
    Aesthetic Plast Surg; 2008 May; 32(3):473-84. PubMed ID: 18224271
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Body image disturbance in body dysmorphic disorder and eating disorders. Obsessions or delusions?
    Phillips KA; Kim JM; Hudson JI
    Psychiatr Clin North Am; 1995 Jun; 18(2):317-34. PubMed ID: 7659601
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacotherapy for obsessive compulsive disorder in clinical practice - Data of 842 inpatients from the International AMSP Project between 1994 and 2012.
    Poppe C; Müller ST; Greil W; Walder A; Grohmann R; Stübner S
    J Affect Disord; 2016 Aug; 200():89-96. PubMed ID: 27130958
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Body dysmorphic disorder.
    Fang A; Matheny NL; Wilhelm S
    Psychiatr Clin North Am; 2014 Sep; 37(3):287-300. PubMed ID: 25150563
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A sociodemographic, phenomenological, and long-term follow-up study of patients with body dysmorphic disorder in Brazil.
    Fontenelle LF; Telles LL; Nazar BP; de Menezes GB; do Nascimento AL; Mendlowicz MV; Versiani M
    Int J Psychiatry Med; 2006; 36(2):243-59. PubMed ID: 17154152
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Psychopharmacological treatment of dermatological patients--when simply talking does not help.
    Harth W; Seikowski K; Gieler U; Niemeier V; Hillert A
    J Dtsch Dermatol Ges; 2007 Dec; 5(12):1101-6. PubMed ID: 17877739
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cognitive-behavioral therapy vs risperidone for augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: a randomized clinical trial.
    Simpson HB; Foa EB; Liebowitz MR; Huppert JD; Cahill S; Maher MJ; McLean CP; Bender J; Marcus SM; Williams MT; Weaver J; Vermes D; Van Meter PE; Rodriguez CI; Powers M; Pinto A; Imms P; Hahn CG; Campeas R
    JAMA Psychiatry; 2013 Nov; 70(11):1190-9. PubMed ID: 24026523
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Augmentation of serotonin reuptake inhibitors in refractory obsessive-compulsive disorder using adjunctive olanzapine: a placebo-controlled trial.
    Bystritsky A; Ackerman DL; Rosen RM; Vapnik T; Gorbis E; Maidment KM; Saxena S
    J Clin Psychiatry; 2004 Apr; 65(4):565-8. PubMed ID: 15119922
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacotherapy for obsessive-compulsive disorder.
    Dougherty DD; Rauch SL; Jenike MA
    J Clin Psychol; 2004 Nov; 60(11):1195-202. PubMed ID: 15389617
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Body dysmorphic disorder in the DSM-IV field trial for obsessive-compulsive disorder.
    Simeon D; Hollander E; Stein DJ; Cohen L; Aronowitz B
    Am J Psychiatry; 1995 Aug; 152(8):1207-9. PubMed ID: 7625473
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Greater history of traumatic event exposure and PTSD associated with comorbid body dysmorphic disorder in a large OCD cohort.
    Valderrama J; Hansen SK; Pato C; Phillips K; Knowles J; Pato MT
    Psychiatry Res; 2020 Jul; 289():112962. PubMed ID: 32446006
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacotherapy for obsessive-compulsive disorder: Real-world evidence from a 10-year retrospective data analysis.
    Oh S; Cho S; Moon SY; Lee J; Kim M; Lee TY; Kwon JS
    Asian J Psychiatr; 2024 Jan; 91():103847. PubMed ID: 38029602
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Insight in body dysmorphic disorder with and without comorbid obsessive-compulsive disorder.
    Marazziti D; Giannotti D; Catena MC; Carlini M; Dell'Osso B; Presta S; Pfanner C; Mungai F; Dell'Osso L
    CNS Spectr; 2006 Jul; 11(7):494-8. PubMed ID: 16816788
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comorbid social anxiety and body dysmorphic disorder: managing the complicated patient.
    Hollander E; Aronowitz BR
    J Clin Psychiatry; 1999; 60 Suppl 9():27-31. PubMed ID: 10335677
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A comparison of quality of life and psychosocial functioning in obsessive-compulsive disorder and body dysmorphic disorder.
    Didie ER; Walters MM; Pinto A; Menard W; Eisen JL; Mancebo M; Rasmussen SA; Phillips KA
    Ann Clin Psychiatry; 2007; 19(3):181-6. PubMed ID: 17729020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.